FDA Panel Flags Insufficient Data for Chronic Cough Drug FDA Panel Flags Insufficient Data for Chronic Cough Drug

Advisers to the FDA said that data on Merck ' s chronic cough drug do not provide sufficient evidence to prove its clinical benefit for patients.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
More News: Cough | Health | Merck